Skip to main content

Advertisement

Table 4 Activity scores in weeks 1, 16 and 28 for SAPHO patients treated with antibiotics

From: Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study

Activity score Week 1 Week 16 Week 28 Pvalue (95% confidence interval)
Skin 2.5 ± 0.5 (1 to 6) 1.2 ± 0.5 (0 to 4) 1.7 ± 0.5 (0 to 5) 0.01 (1.31 to 2.77)a
     0.11 (-1.43 to -0.24)b
     0.09 (-0.17 to 1.84)c
Osteitis 3.5 ± 0.4 (1 to 6) 1.9 ± 0.4 (0 to 4) 2.7 ± 0.5 (0 to 6) 0.01 (1.30 to 2.63)a
     0.01 (-1.43 to -0.24)b
     0.15 (-0.31 to 1.81)c
Erythrocyte sedimentation rate 24.8+-3.3 (9 to 45) 23.3+-2.8 (11 to 36) 25.7+-2.4 (12 to 40) 0.43 (-0.13 to 0.30)a
     0.35 (-0.33 to 0.13)b
     0.34 (-0.20 to 0.53)c
MRI 1.6 ± 0.1 (0 to 2) 1.2 ± 0.1 (0 to 2) 1.4 ± 0.2 (1 to 2) 0.01 (0.44 to 0.89)a
     0.08 (-0.54 to 0.04)b
     0.19 (-0.15 to 0.65)c
Health Assessment Score 3.8 ± 0.4 (2 to 6) 2.2 ± 0.3 (0 to 6) 3.3 ± 0.4 (1 to 6) 0.01 (1.51 to 2.79)a
     0.02 (2.02 to 0.32)b
     0.11 (-0.16 to 1.32)c
  1. Treatment finishing in week 16. Data presented as the mean ± standard error (range); n = 12. aPairwise test (value week 1 vs. value week 16). bPairwise test (value week 16 vs. value week 28). cPairwise test (value week 1 vs. value week 28).